Table 1.
Sociodemographic and clinical description of groups with ALC (n = 41), NALC (n = 34) and healthy controls (n = 21)
| Variables | Groups | n (%) | Mean (SD) | Median (range) |
|---|---|---|---|---|
| Sex (females in %) | ALC | 9 (22%) | – | – |
| NALC | 13 (38%) | – | – | |
| Controls | 12 (57%) | – | – | |
| Age | ALC | – | 55.4 (9.2) | 56.0 (39.0) |
| NALC | – | 57.9 (9.7) | 60.0 (38.0) | |
| Controls | – | 58.0 (7.0) | 58.0 (23.0) | |
| BMI | ALC | – | 27.0 (4.0) | 27.0 (21.7) |
| NALC | – | 27.2 (4.1) | 26.3 (17.0) | |
| Controls | – | 25.0 (3.1) | 25.2 (12.5) | |
| Child–Pugh score | ALC | – | 6.1 (1.4) | 6.0 (6.0) |
| NALC | – | 5.9 (1.3) | 5.0 (5.0) | |
| MELD score | ALC | – | 12.5 (4.4) | 12.4 (19.4) |
| NALC | – | 10.6 (3.4) | 9.7 (11.4) |
ALC alcoholic liver cirrhosis, NALC nonalcoholic liver cirrhosis, SD standard deviation, BMI body mass index, MELD score model of end-stage liver disease score